RxDoctor Payments Data

Morgan Edwards, PA

Physician Assistant · Hickory, NCNPI 1083274575

Payments from drug & device makers

$7,267in general payments, 2019–2025

Across 454 payments — averaging $16.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • AbbVie$1K
  • Pfizer$612
  • Amgen$556
  • GSK$477
  • Lilly USA, LLC$368
  • plus $3K from 47 others

What the payments were for

  • Food & beverage$7,267100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,267 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$50,840
Medicare patients
202
Services billed
1,113

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter101$75,887
MounjaroTirzepatide28$46,019
EliquisApixaban54$45,759
OzempicSemaglutide32$41,751
FarxigaDapagliflozin Propanediol21$27,978
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog14$27,200
JardianceEmpagliflozin23$14,661
Repatha SureclickEvolocumab13$11,943
Breo ElliptaFluticasone/Vilanterol22$9,629
LinzessLinaclotide11$8,188
VascepaIcosapent Ethyl11$8,085
JanumetSitagliptin Phos/Metformin Hcl12$5,801
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$1,964
Atorvastatin Calcium189$1,861
SynthroidLevothyroxine Sodium19$1,495

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$477$85,516123 claims
PfizerEliquis, Paxlovid$612$47,18970 claims
Lilly USA, LLCMounjaro$368$46,01928 claims
Novo NordiskOzempic$332$41,75132 claims
AstraZenecaFarxiga$1,248$27,97821 claims
Boehringer IngelheimJardiance$172$14,66123 claims
AbbVieLinzess, Synthroid$1,016$9,68330 claims
MerckJanumet$43$5,80112 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$30$1,274154 claims
Almatica Pharma LLCSertraline Hcl$14$60493 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Hickory

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →